Spinal Tech

Simplify Medical ended a second tranche of its Series B financing.

The SMART Trial finds favorable results for Relievant Medsystems' Intracept Procedure.

Zimmer Biomet is celebrating two decades of its Rapid Recovery program in Europe.

NuVasive named John DeFord, PhD, to its board of directors.

Smith & Nephew's CEO Olivier Bohuon spoke on a range of topics during the company's quarterly earnings call, discussing 2017 results as well as the potential for growth in 2018. In particular, Mr. Bohuon described the company's research and development…

Here are four device company mergers, acquisitions and agreements.

Patients and physicians more than ever are demanding minimally invasive surgery systems that better patient outcomes and reduce operating time.

On Jan. 30, the FDA released two final revised medical device guidance documents entitled "Refuse to Accept Policy for 510(k)s" and "Acceptance and Filing Reviews for Premarket Approval Applications," The National Law Review reports.

Zimmer Biomet received a Form 483 from the FDA that cited eight issues following a 10-day in inspection in October 2017, according to RAPS.

The FDA granted 34 orthopedic and spine related 510(k) clearances in January 2018.